Catalent, Inc.
CTLTDelisted Dec 18, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001596783
Catalent, Inc. was delisted on Dec 18, 2024; its insiders filed their last Form 4 on Dec 18, 2024; 473 institutions reported holding it in 13F filings for Q3 2024, worth $10.8B in total; Elliott Investment Management was the only superinvestor holding it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 1:39 PM ET
Revenue flow, FY2024
Where the revenue went in FY2024, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Net loss for FY2024: $1.04B (23.8% of revenue).
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 |
| Filing | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Reported | Aug 29, 2024 | Aug 29, 2023 | Aug 29, 2022 | Aug 30, 2021 | Jul 30, 2020 |
| Revenue | $4.38B | $4.26B | $4.80B | $4.00B | $3.09B |
| Cost of revenue | $3.43B | $3.22B | $3.19B | $2.65B | $2.11B |
| Gross profit | $953.0M | $1.04B | $1.61B | $1.35B | $983.3M |
| Research and development | $17.0M | $18.0M | $23.0M | $21.0M | – |
| Selling, general and administrative | $935.0M | $829.0M | $844.0M | $687.0M | $577.9M |
| Operating income | -$749.0M | -$163.0M | $730.0M | $828.0M | $394.4M |
| Income tax | $16.0M | -$86.0M | $80.0M | $130.0M | $39.7M |
| Net income | -$1.04B | -$256.0M | $499.0M | $585.0M | $220.7M |
| EPS, basic | $-5.76 | $-1.42 | $2.74 | $3.15 | $1.16 |
| EPS, diluted | $-5.76 | $-1.42 | $2.73 | $3.11 | $1.14 |
| Weighted shares, basic | 181.0M | 181.0M | 176.0M | 168.0M | 149.8M |
| Weighted shares, diluted | 181.0M | 181.0M | 178.0M | 170.0M | 152.3M |
| Margins and growth | |||||
| Gross margin | 21.8% | 24.4% | 33.6% | 33.8% | 31.8% |
| Operating margin | -17.1% | -3.8% | 15.2% | 20.7% | 12.7% |
| Net margin | -23.8% | -6.0% | 10.4% | 14.6% | 7.1% |
| Revenue growth, year over year | +2.8% | −11.2% | +20.1% | +29.2% | +22.9% |
| Net income growth, year over year | – | −151.3% | −14.7% | +165.1% | +60.6% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2024 | FY2023 | FY2022 | FY2021! | FY2020! |
|---|---|---|---|---|---|
| Period end | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 |
| Filing | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Reported | Aug 29, 2024 | Aug 29, 2023 | Aug 29, 2022 | Aug 30, 2021 | Jul 30, 2020 |
| Cash and equivalents | $289.0M | $280.0M | $449.0M | $896.0M | $953.2M |
| Accounts receivable | $921.0M | $1.00B | $1.05B | $1.01B | $838.1M |
| Inventory | $574.0M | $777.0M | $702.0M | $563.0M | $323.8M |
| Total current assets | $2.60B | $2.69B | $2.92B | $2.92B | $2.29B |
| Property, plant and equipment | $3.64B | $3.68B | $3.13B | $2.52B | $1.90B |
| Goodwill | $2.33B | $3.04B | $3.01B | $2.52B | $2.47B |
| Intangible assets | $841.0M | $980.0M | $1.06B | $817.0M | $888.7M |
| Total assets | $9.75B | $10.8B | $10.5B | $9.11B | $7.78B |
| Accounts payable | $361.0M | $424.0M | $421.0M | $385.0M | $321.0M |
| Short-term debt | $48.0M | $536.0M | $31.0M | $75.0M | $72.9M |
| Total current liabilities | $1.03B | $1.53B | $1.10B | $1.20B | $893.2M |
| Total liabilities | $6.15B | $6.17B | $5.73B | $4.84B | $4.27B |
| Shareholders' equity | $3.60B | $4.61B | $4.78B | $3.92B | $2.90B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Period end | Jun 30, 2024 | Jun 30, 2023 | Jun 30, 2022 | Jun 30, 2021 | Jun 30, 2020 |
| Filing | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Reported | Aug 29, 2024 | Aug 29, 2023 | Aug 29, 2022 | Aug 30, 2021 | Jul 30, 2020 |
| Operating cash flow | $268.0M | $254.0M | $439.0M | $433.0M | $440.3M |
| Capital expenditures | $327.0M | $576.0M | $660.0M | $686.0M | $465.8M |
| Free cash flow | -$59.0M | -$322.0M | -$221.0M | -$253.0M | -$25.5M |
| Depreciation and amortization | $489.0M | $422.0M | $378.0M | $289.0M | $253.7M |
| Stock-based compensation | $68.0M | $35.0M | $54.0M | $51.0M | $48.1M |
| Investing cash flow | -$327.0M | -$955.0M | -$1.88B | -$649.0M | -$827.5M |
| Financing cash flow | $74.0M | $521.0M | $1.03B | $142.0M | $1.00B |
| Net change in cash | $9.00M | -$169.0M | -$447.0M | -$57.0M | $607.8M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 1.6% | 0.8% | 1.1% | 1.3% | 1.6% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Oct 29, 2024 | 181.5M | +0.5% | SEC |
| Oct 23, 2024 | 181.5M | +0.5% | SEC |
| Aug 22, 2024 | 181.5M | +0.5% | SEC |
| Apr 25, 2024 | 181.0M | +0.4% | SEC |
| Jan 31, 2024 | 180.7M | +0.4% | SEC |
| Oct 31, 2023 | 180.6M | +0.4% | SEC |
| Aug 18, 2023 | 180.6M | +0.4% | SEC |
| Apr 30, 2023 | 180.3M | +0.6% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
- A column marked ! failed an accounting identity (gross profit = revenue − cost of revenue, or assets = liabilities + equity, within 1%). Its numbers are shown as filed.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.